Heart Disease News and Research

Latest Heart Disease News and Research

Initial results of MUSIC Trial using PD2i in chronic heart failure patients released

David H. Fater, CEO of Vicor Technologies, Inc., today announced the initial results of a study designed to analyze data from the Merte Subita en Insufficiencia Cardiaca Trial using its PD2i- algorithm and software. Vicor Technologies is a biotechnology company focused on the development of innovative, non-invasive medical devices using its patented, proprietary PD2i- nonlinear algorithm and software.

20 May 2010

Cobalt Pharmaceuticals receives Notice of Compliance from Health Canada to market Atorvastatin Calcium Tablets

Watson Pharmaceuticals, Inc. today announced that its subsidiary Cobalt Pharmaceuticals has received a Notice of Compliance from Health Canada to market Atorvastatin Calcium Tablets in the 10, 20, 40 and 80 mg strengths. Watson has initiated shipments of this product.

20 May 2010

St. Jude Medical to acquire LightLab for $90M in cash

St. Jude Medical, Inc., a global medical device company, and LightLab Imaging, Inc. today announced a definitive agreement under which St. Jude Medical will acquire LightLab, a subsidiary of Goodman Co., Ltd. for approximately $90 million in cash.

20 May 2010

Air pollution associated with cardiopulmonary mortality, morbidity: Researchers

Breathing polluted air increases stress on the heart's regulation capacity, up to six hours after inhalation of combustion-related small particles called PM2.5, according to Penn State College of Medicine researchers.

20 May 2010

Study confirms inverse association of increase in BMI with lower brain volumes

Researchers from Boston University School of Medicine determined that excess abdominal fat places otherwise healthy, middle-aged people at risk for dementia later in life. Preliminary findings suggest a relationship between obesity and dementia that could lead to promising prevention strategies in the future. Results of this study are published early online in Annals of Neurology, a journal of the American Neurological Association.

20 May 2010

Gene therapy shows positive effects in rat models of PAH: Researchers

Gene therapy has been shown to have positive effects in rat models of pulmonary arterial hypertension, according to researchers at the University of Adelaide in Australia.

20 May 2010

Medtronic commences treatment in RESCUE trial of Valiant Thoracic Stent Graft with Captivia Delivery System

Further demonstrating its commitment to proving the benefits of minimally-invasive procedures, Medtronic, Inc., today announced that the first patient has been treated with the company's Valiant® Thoracic Stent Graft with the Captivia Delivery System in Medtronic's RESCUE Clinical Study.

20 May 2010

maxIT Healthcare, Ingenuity Solutions Group enter definitive agreement to merge

maxIT Healthcare, LLC and Ingenuity Solutions Group, Inc. announced today that they have entered into a definitive agreement, under which the companies will be combined as maxIT Healthcare. The combined company is now better positioned to extend its presence throughout the healthcare IT professional services market, particularly in the area of Enterprise Resource Planning (ERP) system solutions.

19 May 2010

ABBOTT PRISM Chagas test receives FDA approval

Abbott received Biologic License Application (BLA) approval from the United States Food and Drug Administration (FDA) for the ABBOTT PRISM Chagas test. The test is a fully automated blood screening assay that can detect antibodies to Trypansoma cruzi (T. cruzi), a parasite found only in the Americas and most commonly acquired through contact with the blood-sucking triatomine or "kissing bug."

19 May 2010

PrimeWire PRESTIGE Pressure Guide Wire receives 510(k) clearance, CE Mark approval

Volcano Corporation announced today it received both 510(k) clearance and CE Mark approval for its PrimeWire PRESTIGE Pressure Guide Wire for use with patients who have both single-vessel and multi-vessel disease. This next generation pressure wire is compatible with Volcano's full suite of integrated multi-modality consoles and stand-alone physiology systems as well as various hemodynamic monitoring systems.

19 May 2010

Abiomed's Impella revenue for full fiscal year 2010 up 59% to $57.8 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2010 revenue of $23.0 million, up 17% compared to revenue of $19.6 million for the same period of fiscal 2009.

19 May 2010

Positive data from Geron's TAT153 small molecule telomerase activator in animal model of IPF

Geron Corporation today announced positive data on its orally available small molecule telomerase activator, TAT153, in an animal model of idiopathic pulmonary fibrosis (IPF). The data show that administration of TAT153 increased telomerase activity in the lung tissue, reduced inflammation, preserved functional lung tissue, slowed disease progression and attenuated loss of pulmonary function.

19 May 2010

SBANE recognizes Isis Biopolymer with 2010 Rising Star Award

Isis Biopolymer has been awarded the 2010 Rising Star Award by SBANE (Smaller Business Association of New England). The Rising Star is a coveted annual award that honors innovative products and services offered by early-stage companies in New England.

19 May 2010

MEDNAX acquires neonatal physician group in Ft. Myers, Florida

MEDNAX, Inc., today announced that it has completed the acquisition of a neonatal physician group in Ft. Myers, Florida.

19 May 2010

Study identifies suppression as a mediator between negative emotions and desire to binge

A German study published in the current issue of Psychotherapy and Psychosomatics explores what is behind binge eating.

19 May 2010

eMedonline telemonitoring system developed to help patients transition from inpatient to outpatient setting

A clinical study is underway at Nyack Hospital to evaluate the use of cellphone-based technology to monitor medication adherence in discharged heart failure patients. The study is using the eMedonline telemonitoring system developed by Leap of Faith Technologies to help patients transition from the inpatient to outpatient setting.

19 May 2010

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

Cell Therapeutics, Inc. reported today preliminary cardiac safety results from a North American randomized phase II trial which substituted pixantrone for doxorubicin in the standard CHOP-R regimen. Called PIX203, the randomized trial compared CPOP-R directly to CHOP-R in the 1st line treatment of high risk patients with diffuse large B cell non-Hodgkin's lymphoma (DLBCL, NHL).

19 May 2010

Loyola conducts heart health-risk assessment and screening program for EMS providers

Research suggests that stress can take its toll on even the toughest first responders. Loyola University Health System is taking steps to protect firefighters and paramedics who risk their lives and perform other heroic measures to help those in need. The organization will offer heart health-risk assessments and screenings to its network of more than 3,000 emergency medical services (EMS) providers. This is part of Loyola's efforts to celebrate its 35th anniversary as an emergency medical services resource hospital.

19 May 2010

Study demonstrates need for understanding societal, economic impact of growing medicalization

Menopause. Normal pregnancy. Infertility. ADHD. Erectile dysfunction. Over the last several decades, these conditions have come to be defined and treated as medical problems. They've been "medicalized." In the first study of its kind in the current issue of Social Science and Medicine, Brandeis researchers used national data to estimate the costs of these and a handful of other common conditions on escalating U.S. healthcare spending.

19 May 2010

Vaccinations recommended for adults

Yearly vaccinations aren't just for kids any more. You probably heard a lot about a seasonal or H1N1 flu shot last fall, but you should know that a battery of other adult vaccinations might also become part of your health care routine. Pneumonia and shingles vaccines are preventive-care essentials for older adults, and meningitis and tetanus shots are now college rites of passage. Even the vaccines of childhood—measles, mumps and rubella, and whooping cough—are recommended for adults who missed out in their younger years.

19 May 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Initial results of MUSIC Trial using PD2i in chronic heart failure patients released

Cobalt Pharmaceuticals receives Notice of Compliance from Health Canada to market Atorvastatin Calcium Tablets

St. Jude Medical to acquire LightLab for $90M in cash

Air pollution associated with cardiopulmonary mortality, morbidity: Researchers

Study confirms inverse association of increase in BMI with lower brain volumes

Gene therapy shows positive effects in rat models of PAH: Researchers

Medtronic commences treatment in RESCUE trial of Valiant Thoracic Stent Graft with Captivia Delivery System

maxIT Healthcare, Ingenuity Solutions Group enter definitive agreement to merge

ABBOTT PRISM Chagas test receives FDA approval

PrimeWire PRESTIGE Pressure Guide Wire receives 510(k) clearance, CE Mark approval

Abiomed's Impella revenue for full fiscal year 2010 up 59% to $57.8 million

Positive data from Geron's TAT153 small molecule telomerase activator in animal model of IPF

SBANE recognizes Isis Biopolymer with 2010 Rising Star Award

MEDNAX acquires neonatal physician group in Ft. Myers, Florida

Study identifies suppression as a mediator between negative emotions and desire to binge

eMedonline telemonitoring system developed to help patients transition from inpatient to outpatient setting

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

Loyola conducts heart health-risk assessment and screening program for EMS providers

Study demonstrates need for understanding societal, economic impact of growing medicalization

Vaccinations recommended for adults

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in